Professor, Pathology, University of Virginia School of Medicine
Pathology
Dr. Christopher A. Moskaluk, MD
|
|
Give Review
Christopher Moskaluk practices Pathology. He went to Duke University School of Medicine. Duke University School of Medicine is a top medical college. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care Christopher Moskaluk is a published MD. He has 76 papers published. The most current publication "Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immun..." Christopher Moskaluk accepts all Medicare patients.
Publications
- Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immun...
- Activin upregulation by NF-κB is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer.
- Adenoid Cystic Carcinoma: A Review of Recent Advances, Molecular Targets and Clinical Trials.
- Sinonasal Tract and Nasopharyngeal Adenoid Cystic Carcinoma: A Clinicopathologic and Immunophenotypic Study of 86 Cases.
- Human Papillomavirus-related Carcinoma With Adenoid Cystic-like Features: A Peculiar Variant of Head and Neck Cancer Restricted to the Sinonasal Tract.
- Proteomic anatomy of human skin.
- Adenoid cystic carcinoma: clinical and molecular features.
- Phase I trial of induction histone deacetylase and proteasome inhibition followed by surgery in non-small-cell lung cancer.
- Sustained activation of the HER1-ERK1/2-RSK signaling pathway controls myoepithelial cell fate in human mammary tissue.
- Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.
- Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell damage, and systemic inflammation in acute pancreatitis.
- Development and characterization of xenograft model systems for adenoid cystic carcinoma.
- Fully Covered Self-Expanding Metal Stents Placed Temporarily in the Bile Duct: Safety Profile and Histologic Classification in a Porcine Model.
- Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
- Integrated, genome-wide screening for hypomethylated oncogenes in salivary gland adenoid cystic carcinoma.
- Loss of VOPP1 overexpression in squamous carcinoma cells induces apoptosis through oxidative cellular injury.
- miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.
- Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas.
- Preoperative chemoradiation for rectal cancer using capecitabine and celecoxib correlated with posttreatment assessment of thymidylate synthase and thymidine phosphory...
- Esophageal inflammatory myofibroblastic tumor sampled by EUS-FNA.
- Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status.
- C-kit gene mutations in adenoid cystic carcinoma are rare.
- Clinical nodal staging of T1-2 tonsillar squamous cell carcinoma stratified by p16 status and implications for ipsilateral neck irradiation.
- Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers.
- Mucus rupture (extrusion) and duct expansion/expansive growth are not diagnostic of minimal invasion when seen with intraductal papillary mucinous neoplasms.
- Microchip-based solid-phase purification of RNA from biological samples.
- The continued supremacy of qualitative interpretation over quantitative measurement in histologic tissue assessment: collagenous colitis as a case in point.
- Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients Wi...
- Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
- Clinical challenges and images in GI. Ganglioneuromatosis polyposis.
- Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: serial analysis of gene expression.
- Re: the feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
- Concurrent loss of heterozygosity and copy number analysis in adenoid cystic carcinoma by SNP genotyping arrays.
- The level of carcinoembryonic antigen and the presence of mucin as predictors of cystic pancreatic mucinous neoplasia.
- Measurement of the invasion depth of extrahepatic bile duct carcinoma: An alternative method overcoming the current T classification problems of the AJCC staging system.
- Distribution of the AQP4 water channel in normal human tissues: protein and tissue microarrays reveal expression in several new anatomical locations, including the pro...
- The mismatch repair protein status of colorectal small cell neuroendocrine carcinomas.
- Reconsideration of the histologic definitions used in the pathologic staging of extrahepatic bile duct carcinoma.
- The prevalence of pancreatic intraepithelial neoplasia in pancreata with uncommon types of primary neoplasms.
- AP-2gamma protein expression in intratubular germ cell neoplasia of testis.
- Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinoma.
- Tissue processing re-visited: a shifting paradigm in surgical pathology.
- CDX2 and MUC2 protein expression in extrahepatic bile duct carcinoma.
- Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis.
- Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis.
- Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease.
- Tissues from population-based cancer registries: a novel approach to increasing research potential.
- Vanishing prostate cancer syndrome: symptom of a larger clinical issue.
- Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas.
- CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray.
- Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc mice and in human Crohn''s disease.
- Factors predictive of malignancy and endoscopic resectability in ampullary neoplasia.
- Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.
- Clustering of molecular alterations in gastroesophageal carcinomas.
- Decreased abundance of trefoil factor 1 transcript in the majority of gastric carcinomas.
- Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
- Overexpression of the 32-kilodalton dopamine and cyclic adenosine 3',5'-monophosphate-regulated phosphoprotein in common adenocarcinomas.
- Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays.
- Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc.
- TNF-alpha neutralization ameliorates the severity of murine Crohn's-like ileitis by abrogation of intestinal epithelial cell apoptosis.
- Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas.
- Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis.
- Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum.
- Gastric cancers overexpress S100A calcium-binding proteins.
- Agarose mold embedding of cultured cells for tissue microarrays.
- RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.
- Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease.
- Standardization of clinical immunohistochemistry: why, how, and by whom?
- The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells.
- Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.
- Interpretation of RET immunostaining in follicular lesions of the thyroid.
- Genetic analysis of invasive carcinoma arising in intraductal oncocytic papillary neoplasm of the pancreas.
- Gastric cancers overexpress DARPP-32 and a novel isoform, t-DARPP.
- Intestinal ischemia and peripheral gangrene in a patient with chronic renal failure.
- Distinct Expression Patterns of ICK/MAK/MOK Protein Kinases in the Intestine Implicate Functional Diversity.
Schools
Duke University
National Institutes Of Health
Johns Hopkins Hospital
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Pathway X Tier Hosp HealthKeepers DirectAccess VA
- HealthKeepers HMO
- KeyCare PPO
- Blue Card PPO
- CHAMPVA
- Cigna
- Commercial Insurance Company
- Coventry Health Care
- Golden Rule
- Humana
- MedCost PPO
- Medicare MCR
- Meritain Health
- Pyramid Life
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
National Institutes of Health Clinical Center -
Duke University School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1659440287 |
| Last Name Of The Provider | MOSKALUK |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
|
Dr. Dennis J. Templeton, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott B. Vande Pol, MD |
|
|
Dr. Henry F. Frierson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert E. Fechner, MD |
|
|
Dr. R H. MacMillan III, MD |
|
|
Dr. Thomas W. Tillack, MD |
|
|
Dr. Kuldeep Teja, MD |
|
|
Dr. Julia C. Iezzoni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rahat M. Bhatti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne M. Mills, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa C. Myers, MD |
|
|
Dr. Paul D. Mintz, MD |